NINA KUSHNER: Open Payments
NPI 1104801091 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 51 payments from 15 companies in 2025. Trend: 2023 $745 · 2024 $1,557 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $417 |
| Axsome Therapeutics, Inc. | 8 | $217 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Aimmune Therapeutics, Inc. | 4 | $113 |
| Novo Nordisk Inc | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Philips North America LLC | 1 | $32 |
| PFIZER INC. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: LINZESS, Auvelity, CREON, ZENPEP, GEMTESA, Symbravo, Wegovy, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
